An experimental malaria vaccine created by “an approach pioneered more than 30 years ago but abandoned as wildly impractical” is about to be tested on humans, the Seattle Times reports.
“The first clinical trial of an HIV/AIDS vaccine designed and developed in South Africa was launched in Cape Town” Monday, the SAPA/The Times reports.
Male circumcision does not prevent the transmission of HIV from men to their female partners, according to a Lancet study conducted in Uganda, Bloomberg reports.
Also In Global Health News: India Drought; NTD Research; HIV/AIDS In Beijing And African Militaries; Malaria Vaccine
Near Drought In India Is ‘Matter Of Concern’ The Observer examines the water shortage in India. “India’s vast farming economy is on the verge of crisis. The lack of rain has hit northern areas most, but even in Mumbai, which has experienced heavy rainfall and flooding, authorities were forced to…
The WHO on Wednesday announced plans for a clinical trial to test a new drug that “could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa,” AFP/CNN Money reports.
In malaria-endemic areas, vitamin A supplements â€“ which cost about 2 U.S. cents each â€“ can help reduce infections in children by one-third, according to a study published in the Malaria Journal, IRIN reports
Also In Global Health News: Children With HIV/AIDS; Leishmaniasis Treatment; ITNs In Tanzania; U.S. Malaria Fight; PEPFAR Safe Injection Funds
IRIN Examines Hardships Facing Parents, Guardians Of Children Living With HIV/AIDS IRIN examines the hardships parents and guardians of the estimated 170,000 Kenyan children currently infected with HIV often face. “Caregivers face the dilemma of how to disclose status to … [HIV-positive] children, and to whom,” as well as other…
The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports.
The pharmaceutical company Tibotec said it will join with the non-profit Global Alliance for Tuberculosis Development (TB Alliance) to speed up the development of the experimental TB drug TMC207, Health-e/IOL reports.
The Globe and Mail examines GlaxoSmithKline’s RTS,S malaria vaccine trials in Kilifi, Kenya â€“ one of the sites where the experimental vaccine is being tested.